Abstract:Bone regeneration in dentistry is a dynamic approach for treating critical size bone defects that are unlikely to self-heal. Human bone marrow stem cell (hBMSCs) therapies are being tested clinically for various disorders and have remarkable clinical advancements in bone regeneration. Injectable platelet-rich fibrin (i-PRF), which is obtained from autologous blood centrifuged at 700 rpm (60 G) for 3 min can promote osteogenic differentiation of this cell, but the mechanism remains unclear. The objectives of this study were to explore the contents of i-PRF further and investigate its effect on the cell behavior of hBMSCs and the underlying molecular mechanisms. The results showed that i-PRF contained 41 cytokines, including macrophage colony-stimulating factor (M-CSF) and β-nerve growth factor (β-NGF), which had not been reported before. The Cell Counting Kit-8 and wound healing assay showed that 10% and 20% i-PRF improved the proliferation rate and the migration capacity of hBMSCs without toxicity to cells. Besides, the expression of osteogenic markers and the capacity to form mineralized nodules of hBMSCs were promoted by 20% i-PRF. Furthermore, i-PRF activated the ERK pathway, and the ERK inhibitor attenuated its effects. In summary, i-PRF promotes hBMSCs proliferation and migration and facilitates cell osteogenesis through the ERK pathway, which has promising potential in bone regeneration. What is the context? Bone defects caused by trauma or tumor is a great challenge in clinical practice. However, there is the good news that the bone defect in the oral can self-regenerate, the bone remodeling may take several months to several years and shows apparent individual differences. Different strategies, surgical techniques, and materials have been employed to induce an optimal outcome in guided bone regeneration. Blood products have been widely used in dentistry due to their excellent biocompatibility, growth factor content, ease of collection, and ability to be produced by the human body. Limited data suggest that Injectable platelet-rich fibrin positively regulates osteogenic differentiation of stem cells, but further evidence is needed to quantify this effect. What is new? It is unclear how many growth factors i-PRF contains in previous studies, so we detected 41 kinds of growth factors, more than has been previously appreciated, and found that all growth factors were measured in the samples, and the difference was in the amount of expression. In our research, we explored the role of i-PRF in the osteogenesis of hBMSCs through the effects of different concentrations of i-PRF on the proliferation, migration, and osteogenic differentiation of hBMSCs. Currently, most current research focuses on observing phenomena, and we wondered by what mechanism the i-PRF regulates stem cell function. We found that i-PRF can regulate the molecular mechanism of the osteogenic differentiation of hBMSCs in vitro by activating the MAPK/ERK signaling pathway. What is the impact? I-PRF promotes hBMSCs proliferation and migration and facilitates cell osteogenesis through the ERK pathway. The favorable cytobiological effects of i-PRF on hBMSCs might be the basis for i-PRF applications in bone regenerative.

The effect of injectable platelet-rich fibrin and platelet-rich fibrin in regenerative endodontics: a comparative in vitro study

The in vitro efficacy of advanced platelet-rich fibrin plus versus injectable platelet-rich fibrin on the proliferation, migration, and differentiation of stem cells from apical papilla

Quantification of growth factors in advanced platelet-rich fibrin and concentrated growth factors and their clinical efficiency as adjunctive to the GTR procedure in periodontal intrabony defects

Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry?

Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma

Effect of platelet-rich fibrin and concentrated growth factor on the regenerative potential of human-induced pluripotent stem cells: A comparative analysis

Comparative evaluation of the osteogenic capacity of second-generation platelet concentrates on dental pulp stem cells - An ex vivo study

Injectable platelet-rich fibrin positively regulates osteogenic differentiation of stem cells from implant hole via the ERK1/2 pathway

The Effects of Injectable Platelet-Rich Fibrin and Advanced-Platelet Rich Fibrin on Gingival Fibroblast Cell Vitality, Proliferation, Differentiation.

Behavior of Gingival Fibroblasts on Titanium Implant Surfaces in Combination with Either Injectable-PRF or PRP

Study of platelet-rich fibrin combined with rat periodontal ligament stem cells in periodontal tissue regeneration.

The Effect of Different Platelet-Rich Plasma Concentrations on Proliferation and Differentiation of Human Periodontal Ligament Cells in Vitro

Effect of Liquid Platelet-rich Fibrin and Platelet-rich Plasma on the Regenerative Potential of Dental Pulp Cells Cultured under Inflammatory Conditions: A Comparative Analysis.

Utilizing 3D bioprinted platelet-rich fibrin-based materials to promote the regeneration of oral soft tissue

Comparison between PRP vs iPRF as an adjunct therapy in Infra-bony Pocket treatment

Potential Dental Pulp Revascularization and Odonto-/Osteogenic Capacity of a Novel Transplant Combined with Dental Pulp Stem Cells and Platelet-Rich Fibrin

Platelet-Rich Fibrin Promotes Periodontal Regeneration and Enhances Alveolar Bone Augmentation

Autogenous platelet concentrates for treatment of intrabony defects—A systematic review with meta‐analysis

Improved growth factor delivery and cellular activity using concentrated platelet-rich fibrin (C-PRF) when compared with traditional injectable (i-PRF) protocols

The Effects of Leukocyte-Platelet Rich Fibrin (L-PRF) on Suppression of the Expressions of the Pro-Inflammatory Cytokines, and Proliferation of Schwann Cell, and Neurotrophic Factors

Use of Platelet-Rich Fibrin in the Treatment of Periodontal Intrabony Defects: A Systematic Review and Meta-Analysis